• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症临床发病时上下运动神经元变性的局灶性

Focality of upper and lower motor neuron degeneration at the clinical onset of ALS.

作者信息

Ravits John, Paul Piper, Jorg Cathy

机构信息

Neurogenomics Laboratory, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA.

出版信息

Neurology. 2007 May 8;68(19):1571-5. doi: 10.1212/01.wnl.0000260965.20021.47.

DOI:10.1212/01.wnl.0000260965.20021.47
PMID:17485643
Abstract

OBJECTIVE

To localize and analyze the anatomic distribution of upper motor neuron (UMN) and lower motor neuron (LMN) loss in patients with ALS early in their disease when motor manifestations were still relatively focal using clinical examination signs.

METHODS

We reviewed records of 100 patients with ALS who were evaluated when the diagnosis was first established or suspected. From the patient history, we ascertained the body region of first symptoms and the time course. From the physical examination, we separately graded severity of UMN and LMN signs in each body region, indexed these to the body region of first symptoms, and sorted and analyzed the data.

RESULTS

Motor manifestations began in one body region in 98% of patients. UMN and LMN signs were both maximal in these same body regions, but they were independent of each other in severity and their outward distribution, which conformed to neuronal anatomy. The outward distribution of both UMN and LMN signs seemed more directed to caudal body regions than to rostral ones.

CONCLUSIONS

Motor neuron degeneration in ALS is a focal process at both upper and lower motor neuron levels of the motor system. At each level, it begins corresponding to the same peripheral body region and then advances contiguously and separately to summate over time.

摘要

目的

在运动症状仍相对局限的肌萎缩侧索硬化症(ALS)患者疾病早期,利用临床检查体征定位并分析上运动神经元(UMN)和下运动神经元(LMN)损失的解剖分布。

方法

我们回顾了100例首次确诊或疑似ALS患者的记录。从患者病史中,我们确定首发症状的身体部位和病程。通过体格检查,我们分别对每个身体部位的UMN和LMN体征严重程度进行分级,将这些分级与首发症状的身体部位相关联,并对数据进行分类和分析。

结果

98%的患者运动症状始于一个身体部位。UMN和LMN体征在这些相同的身体部位均最为明显,但它们在严重程度和外在分布上相互独立,这与神经元解剖结构相符。UMN和LMN体征的外在分布似乎更多地指向身体的尾端区域而非头端区域。

结论

ALS中的运动神经元变性在运动系统的上运动神经元和下运动神经元水平均为局灶性过程。在每个水平,它始于相应的外周身体部位,然后随着时间的推移持续且分别进展并累加。

相似文献

1
Focality of upper and lower motor neuron degeneration at the clinical onset of ALS.肌萎缩侧索硬化症临床发病时上下运动神经元变性的局灶性
Neurology. 2007 May 8;68(19):1571-5. doi: 10.1212/01.wnl.0000260965.20021.47.
2
Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem.肌萎缩侧索硬化症局灶性的意义:死后下运动神经元损失的头尾分布
Neurology. 2007 May 8;68(19):1576-82. doi: 10.1212/01.wnl.0000261045.57095.56.
3
Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.区分进行性延髓麻痹(PLS)、上运动神经元为主型肌萎缩侧索硬化症(ALS)和典型ALS的临床特征。
Neurology. 2009 Jun 2;72(22):1948-52. doi: 10.1212/WNL.0b013e3181a8269b.
4
ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.肌萎缩侧索硬化症的运动表型异质性、局灶性和扩散:解析运动神经元变性
Neurology. 2009 Sep 8;73(10):805-11. doi: 10.1212/WNL.0b013e3181b6bbbd.
5
Spreading in ALS: The relative impact of upper and lower motor neuron involvement.ALS 中的扩散:上下运动神经元受累的相对影响。
Ann Clin Transl Neurol. 2020 Jul;7(7):1181-1192. doi: 10.1002/acn3.51098. Epub 2020 Jun 18.
6
The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach.上运动神经元和下运动神经元负担对脊髓型肌萎缩症诊断确定性和临床病程的影响:基于聚类的方法。
J Neurol. 2023 Oct;270(10):4868-4875. doi: 10.1007/s00415-023-11827-7. Epub 2023 Jun 20.
7
The degeneration of upper and lower motor neuron from the perspective of clinical neurological examination and MRI-electromyography manifold detection in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中临床神经内科检查和 MRI-肌电图联合检测的上下运动神经元变性。
Neuroreport. 2021 Jan 6;32(1):23-28. doi: 10.1097/WNR.0000000000001555.
8
Hyperintensity of the corticospinal tract on FLAIR: A simple and sensitive objective upper motor neuron degeneration marker in clinically verified amyotrophic lateral sclerosis.液体衰减反转恢复序列(FLAIR)上皮质脊髓束高信号:临床确诊的肌萎缩侧索硬化症中一种简单且敏感的客观上运动神经元变性标志物。
J Neurol Sci. 2016 Aug 15;367:177-83. doi: 10.1016/j.jns.2016.06.005. Epub 2016 Jun 3.
9
Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症受累部位运动表现的上下运动神经元变性的优势异质性。
Sci Rep. 2019 Dec 27;9(1):20059. doi: 10.1038/s41598-019-56665-8.
10
Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis.进行性肌肉萎缩中运动神经元的差异受累:与肌萎缩侧索硬化症的比较研究
BMJ Open. 2014 May 14;4(5):e005213. doi: 10.1136/bmjopen-2014-005213.

引用本文的文献

1
Identification of passive wrist-worn accelerometry outcomes for improved disease monitoring and trial design in motor neuron disease.确定用于改善运动神经元疾病的疾病监测和试验设计的被动式腕部佩戴式加速度计测量结果。
EBioMedicine. 2025 May 29;117:105779. doi: 10.1016/j.ebiom.2025.105779.
2
Longitudinal assessment of cortical motor function in amyotrophic lateral sclerosis.肌萎缩侧索硬化症皮质运动功能的纵向评估
Sci Rep. 2025 May 15;15(1):16978. doi: 10.1038/s41598-025-01570-6.
3
Pathophysiology, Clinical Heterogeneity, and Therapeutic Advances in Amyotrophic Lateral Sclerosis: A Comprehensive Review of Molecular Mechanisms, Diagnostic Challenges, and Multidisciplinary Management Strategies.
肌萎缩侧索硬化症的病理生理学、临床异质性及治疗进展:分子机制、诊断挑战与多学科管理策略的全面综述
Life (Basel). 2025 Apr 14;15(4):647. doi: 10.3390/life15040647.
4
Asymmetry in amyotrophic lateral sclerosis: Clinical, neuroimaging and histological observations.肌萎缩侧索硬化症中的不对称性:临床、神经影像学和组织学观察。
Brain. 2025 Aug 1;148(8):2605-2615. doi: 10.1093/brain/awaf121.
5
CREB3 gain of function variants protect against ALS.CREB3功能获得性变体可预防肌萎缩侧索硬化症。
Nat Commun. 2025 Mar 26;16(1):2942. doi: 10.1038/s41467-025-58098-6.
6
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration.小胶质细胞在神经退行性疾病中蛋白质聚集体的朊病毒样传播中的作用。
Brain Commun. 2025 Feb 25;7(2):fcaf087. doi: 10.1093/braincomms/fcaf087. eCollection 2025.
7
Molecular and cellular characteristics of cerebrovascular cell types and their contribution to neurodegenerative diseases.脑血管细胞类型的分子和细胞特征及其对神经退行性疾病的影响。
Mol Neurodegener. 2025 Jan 29;20(1):13. doi: 10.1186/s13024-025-00799-z.
8
The Scientific and Therapeutic Rationale for Off-Label Treatments in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症超说明书治疗的科学与治疗原理
Ann Neurol. 2024 Nov 6;97(1):15-27. doi: 10.1002/ana.27126.
9
Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS.肌萎缩侧索硬化症上运动神经元功能障碍的生理生物标志物
Brain Sci. 2024 Jul 29;14(8):760. doi: 10.3390/brainsci14080760.
10
Potential contribution of spinal interneurons to the etiopathogenesis of amyotrophic lateral sclerosis.脊髓中间神经元对肌萎缩侧索硬化症发病机制的潜在作用。
Front Neurosci. 2024 Jul 18;18:1434404. doi: 10.3389/fnins.2024.1434404. eCollection 2024.